Propanc Biopharma, Inc. (PPCB)
2.14
+0.03
(+1.42%)
USD |
NASDAQ |
Oct 29, 10:04
Propanc Biopharma Market Cap : 7.085M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 6.986M |
| October 27, 2026 | 8.045M |
| October 26, 2026 | 7.582M |
| October 23, 2026 | 9.270M |
| October 22, 2026 | 9.072M |
| October 21, 2026 | 10.44M |
| October 20, 2026 | 10.63M |
| October 19, 2026 | 1.050M |
| October 16, 2026 | 1.132M |
| October 15, 2026 | 1.131M |
| October 14, 2026 | 1.211M |
| October 13, 2026 | 1.366M |
| October 12, 2026 | 1.457M |
| October 09, 2026 | 1.608M |
| October 08, 2026 | 1.559M |
| October 07, 2026 | 1.651M |
| October 06, 2026 | 1.627M |
| October 05, 2026 | 1.655M |
| October 02, 2026 | 1.680M |
| October 01, 2026 | 1.659M |
| September 30, 2026 | 1.636M |
| September 29, 2026 | 1.696M |
| September 28, 2026 | 1.766M |
| September 25, 2026 | 2.087M |
| September 24, 2026 | 1.992M |
| Date | Value |
|---|---|
| September 23, 2026 | 2.079M |
| September 22, 2026 | 2.155M |
| September 21, 2026 | 0.5506M |
| September 18, 2026 | 0.5334M |
| September 17, 2026 | 0.5509M |
| September 16, 2026 | 0.5552M |
| September 15, 2026 | 0.717M |
| September 14, 2026 | 0.7432M |
| September 11, 2026 | 0.8053M |
| September 10, 2026 | 0.8244M |
| September 09, 2026 | 0.8657M |
| September 08, 2026 | 0.9006M |
| September 04, 2026 | 0.8831M |
| September 03, 2026 | 0.8919M |
| September 02, 2026 | 0.9006M |
| September 01, 2026 | 0.9881M |
| August 31, 2026 | 1.180M |
| August 28, 2026 | 1.180M |
| August 27, 2026 | 1.950M |
| August 26, 2026 | 0.9356M |
| August 25, 2026 | 0.9881M |
| August 24, 2026 | 1.010M |
| August 21, 2026 | 0.9444M |
| August 20, 2026 | 0.9618M |
| August 19, 2026 | 0.9968M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 24.17M |
| CSL Ltd. | 66.59B |
| Ceryvyn Therapeutics Ltd. | 3.95M |
| Mesoblast Ltd. | 2.001B |
| Actinogen Medical Ltd. | 96.77M |
Market Cap Related Metrics
| Price to Book Value | 0.7536 |
| Price | 2.14 |
| Earnings Yield | -1.21K% |